[Form 4] Oportun Financial Corporation Insider Trading Activity

Rhea-AI Filing Summary

Warren Wilcox, a director of Oportun Financial Corporation (OPRT), received a grant of 18,041 restricted stock units (RSUs) reported on Form 4. The transaction date is 08/19/2025 and the Form 4 was signed on 08/21/2025. The RSUs vest in four equal installments: October 18, 2025; January 18, 2026; April 18, 2026; and upon the earlier of the day before the issuer's 2026 annual meeting or July 18, 2026, subject to continued service through each vesting date. Each RSU converts to one share of common stock at settlement. Following the reported acquisition, the reporting person beneficially owns 18,041 shares directly.

Positive

• Grant quantity and vesting schedule clearly disclosed: 18,041 RSUs with four equal vesting dates (Oct 18, 2025; Jan 18, 2026; Apr 18, 2026; earlier of day before 2026 annual meeting or Jul 18, 2026).
• Each RSU converts to one share: The filing explicitly states each RSU represents the right to receive one share of common stock at settlement.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received a grant of 18,041 RSUs with a clear four-step vesting schedule; size appears modest relative to companywide equity plans.

The Form 4 discloses a non-cash equity grant to a director rather than an open-market purchase or sale. The award vests in four equal tranches across late 2025 and mid-2026 and converts one-for-one into common shares at settlement. This is a routine director compensation event intended to deliver equity over time. The filing provides exact dates and quantity but no dollar value or percentage of outstanding shares, so assessment of materiality relative to total share count cannot be determined from this form alone.

Corporate Governance Expert

TL;DR: Grant is a standard restricted stock unit award for a director with service-based vesting; disclosure meets Section 16 requirements.

The Form 4 properly reports the award date, quantity, vesting schedule, and that each RSU equals one share. The vesting conditions are service-based with a specified accelerated final tranche tied to the annual meeting or a calendar date. The filing is signed by an attorney-in-fact and shows direct beneficial ownership post-grant. The document does not provide plan terms, grant approval details, or whether vesting is subject to other conditions, so further governance context is not available here.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILCOX WARREN

(Last) (First) (Middle)

C/O OPORTUN FINANCIAL CORPORATION

2 CIRCLE STAR WAY

(Street)

SAN CARLOS CA 94070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oportun Financial Corp [ OPRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		A		18,041(1)	A	(2)	18,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units that will vest one-fourth on each of October 18, 2025, January 18, 2026, April 18, 2026, and upon the earlier of (i) the date immediately preceding the Issuer's 2026 annual stockholder meeting or (ii) July 18, 2026, subject to the Reporting Person's continued service through such date.

2. Each RSU represents the right to receive, at settlement, one share of common stock.

Remarks:

	/s/Kathleen Layton (Attorney-in-Fact)	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OPRT director Warren Wilcox receive on 08/19/2025?

Warren Wilcox received 18,041 restricted stock units (RSUs) reported on Form 4 with transaction date 08/19/2025.

When do the 18,041 RSUs vest for OPRT director Warren Wilcox?

The RSUs vest one-fourth on each of: October 18, 2025; January 18, 2026; April 18, 2026; and upon the earlier of the day before the 2026 annual meeting or July 18, 2026, subject to continued service.

How many shares does each RSU convert into for OPRT?

Each RSU represents the right to receive one share of common stock at settlement, as stated in the filing.

What is the beneficial ownership reported after the transaction?

The reporting person beneficially owns 18,041 shares directly following the reported transaction.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Kathleen Layton (Attorney-in-Fact) on 08/21/2025, as shown on the filing.